NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

4 - MAHON PAUL A

Filed: 2026-04-16 AccNo: 0001231589-26-000010 Size: 17 KB
发布时间04/16 20:30 UTC
首次发现04/16 20:37 UTC
热度106.2
重要度74
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 517 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001231589-26-000010

Filing Date: 2026-04-16

Accepted: 2026-04-16 16:30:56

Documents: 1

Period of Report: 2026-04-16

UNITED THERAPEUTICS Corp ( Issuer ) CIK : 0001082554 (see all company filings) EIN. : 521984749 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | PRIMARY DOCUMENT | primarydocument.html | 4

1 | PRIMARY DOCUMENT | primarydocument.xml | 4